Inovio Pharma (INO) Posts Q4 Loss of 25c/Share
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.20 +4.35%
Financial Fact:
Net loss/ (gain) attributable to non-controlling interest: 0
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Net loss/ (gain) attributable to non-controlling interest: 0
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q4 EPS of ($0.25), which may not compare with the analyst estimate of ($0.20). Revenue for the quarter came in at $5.94 million versus the consensus estimate of $6.96 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- OMNIQ Corp. posts Q2 2026 revenue of $7.4M, widens net loss
- Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
